基于AHP-FCE模型的制药行业清洁生产技术评价

Evaluation of cleaner production technologies in pharmaceutical industry based on AHP-FCE model

  • 摘要: 在制药行业推行清洁生产技术,从源头减少污染物的产生,有利于促进制药行业的健康、可持续发展。为正确选择适合的制药行业清洁生产技术,建立了包含技术、经济和环境指标的制药行业清洁生产技术评价指标体系,构建了层次分析法-模糊综合评价法(AHP-FCE)评价模型,确定了制药行业清洁生产技术的评价标准,并对4项制药行业清洁生产技术进行了综合评价。结果表明:在技术性能方面表现较优的是头孢氨苄酶法合成技术,在经济性能方面表现较优的是抗生素合成固定化酶规模化制备技术,在环境性能方面表现较优的是基于培养基替代的青霉素发酵减排技术;技术综合得分表明,头孢氨苄酶法合成技术是4项制药行业清洁生产技术中的最优技术。

     

    Abstract: The implementation of cleaner production technologies in the pharmaceutical industry can reduce the generation of pollutants from the source, which is conducive to promoting the healthy and sustainable development of the pharmaceutical industry. In order to correctly select the appropriate cleaner production technologies in the pharmaceutical industry, the evaluation index system of cleaner production technologies in the pharmaceutical industry including technical, economic and environmental indexes was established, and the analytic hierarchy process-fuzzy comprehensive evaluation (AHP-FCE) model was constructed. The evaluation standard of cleaner production technologies in the pharmaceutical industry was determined, and the comprehensive evaluation of four cleaner production technologies in the pharmaceutical industry was carried out based on the AHP-FCE model. The results showed that cephalexin enzymatic synthesis technology was better in technical performance, large-scale preparation technology of immobilized enzyme for antibiotic synthesis was better in economic performance, and penicillin fermentation and emission reduction technology based on medium substitution was better in environmental performance. The comprehensive evaluation results showed that cephalexin enzymatic synthesis technology was the best technology in four cleaner production technologies in pharmaceutical industry.

     

/

返回文章
返回